Redwire Lands $25M NASA Contract for ISS Support Services
PorAinvest
viernes, 29 de agosto de 2025, 7:19 pm ET1 min de lectura
RDW--
The contract includes a recent $2.5 million task order from NASA's In Space Production Applications (InSPA) program, which will support additional drug development investigations on the ISS using Redwire's PIL-BOX technology [1]. Redwire will provide turnkey services to manage, integrate, and facilitate experiments and support on-orbit operations for NASA-funded research investigations aboard the ISS.
Redwire's capabilities are intended to support the diverse set of life and materials sciences research investigations that NASA processes every year. The company's expertise in microgravity research and development technologies has enabled it to support notable research partners such as Bristol Myers Squibb, Eli Lilly and Company, and Butler University [2].
Redwire's PIL-BOX technology, which allows for the growth of crystals in microgravity, has been a key asset in advancing space biotechnology and pharmaceutical development. The company recently formed SpaceMD, a new entity focused on growing seed crystals in orbit for use on Earth to create new and reformulated pharmaceuticals [2].
This contract underscores Redwire's role as a global leader in space and defense technology solutions, with a strong focus on biotechnology and microgravity research. The company's approximately 1,300 employees are committed to delivering innovative space and airborne platforms that transform multi-domain operations [2].
References:
[1] https://www.marketscreener.com/news/redwire-receives-25-million-single-award-idiq-contract-by-nasa-to-provide-biotechnology-and-support-ce7c50dfd18cff21
[2] https://redwirespace.com/newsroom/redwire-awarded-25-million-single-award-idiq-contract-by-nasa-to-provide-biotechnology-and-support-on-orbit-operations-aboard-the-international-space-station/
Redwire has been awarded a $25M IDIQ contract by NASA for a five-year period to provide biotechnology facilities, on-orbit operations support, mission integration, and related services for the agency on the International Space Station. The contract has a $25M ceiling and Redwire was recently issued a $2.5M task order to support drug development investigations on the ISS using its PIL-BOX technology.
Redwire Corporation has been awarded a $25 million, five-year indefinite-delivery/indefinite-quantity (IDIQ) contract by NASA to provide biotechnology facilities, on-orbit operations support, mission integration, and related services for the International Space Station (ISS). This contract, with a ceiling of $25 million, was announced on August 28, 2025 [2].The contract includes a recent $2.5 million task order from NASA's In Space Production Applications (InSPA) program, which will support additional drug development investigations on the ISS using Redwire's PIL-BOX technology [1]. Redwire will provide turnkey services to manage, integrate, and facilitate experiments and support on-orbit operations for NASA-funded research investigations aboard the ISS.
Redwire's capabilities are intended to support the diverse set of life and materials sciences research investigations that NASA processes every year. The company's expertise in microgravity research and development technologies has enabled it to support notable research partners such as Bristol Myers Squibb, Eli Lilly and Company, and Butler University [2].
Redwire's PIL-BOX technology, which allows for the growth of crystals in microgravity, has been a key asset in advancing space biotechnology and pharmaceutical development. The company recently formed SpaceMD, a new entity focused on growing seed crystals in orbit for use on Earth to create new and reformulated pharmaceuticals [2].
This contract underscores Redwire's role as a global leader in space and defense technology solutions, with a strong focus on biotechnology and microgravity research. The company's approximately 1,300 employees are committed to delivering innovative space and airborne platforms that transform multi-domain operations [2].
References:
[1] https://www.marketscreener.com/news/redwire-receives-25-million-single-award-idiq-contract-by-nasa-to-provide-biotechnology-and-support-ce7c50dfd18cff21
[2] https://redwirespace.com/newsroom/redwire-awarded-25-million-single-award-idiq-contract-by-nasa-to-provide-biotechnology-and-support-on-orbit-operations-aboard-the-international-space-station/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios